Top compounds associated with response to TCF25


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA austocystin d CTRPv2 pan-cancer AAC -0.11 0.003
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.096 0.006
mRNA BIRB 0796 FIMM pan-cancer AAC 0.47 0.009
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.074 0.01
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.094 0.01
Download CSV